"Dronabinol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A psychoactive compound extracted from the resin of Cannabis sativa (marihuana, hashish). The isomer delta-9-tetrahydrocannabinol (THC) is considered the most active form, producing characteristic mood and perceptual changes associated with this compound.
| Descriptor ID |
D013759
|
| MeSH Number(s) |
D02.455.849.090.810
|
| Concept/Terms |
Dronabinol- Dronabinol
- delta(9)-THC
- 9-ene-Tetrahydrocannabinol
- 9 ene Tetrahydrocannabinol
- THC
- delta(1)-Tetrahydrocannabinol
- delta(1)-THC
- delta(9)-Tetrahydrocannabinol
- Tetrahydrocannabinol
|
Below are MeSH descriptors whose meaning is more general than "Dronabinol".
Below are MeSH descriptors whose meaning is more specific than "Dronabinol".
This graph shows the total number of publications written about "Dronabinol" by people in this website by year, and whether "Dronabinol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1998 | 1 | 1 | 2 |
| 2001 | 4 | 0 | 4 |
| 2003 | 2 | 0 | 2 |
| 2004 | 3 | 0 | 3 |
| 2005 | 2 | 0 | 2 |
| 2006 | 3 | 0 | 3 |
| 2007 | 3 | 1 | 4 |
| 2008 | 2 | 0 | 2 |
| 2009 | 7 | 0 | 7 |
| 2010 | 5 | 1 | 6 |
| 2011 | 5 | 4 | 9 |
| 2012 | 5 | 3 | 8 |
| 2013 | 6 | 3 | 9 |
| 2014 | 5 | 5 | 10 |
| 2015 | 3 | 2 | 5 |
| 2016 | 1 | 7 | 8 |
| 2017 | 3 | 1 | 4 |
| 2018 | 3 | 0 | 3 |
| 2019 | 1 | 2 | 3 |
| 2020 | 4 | 4 | 8 |
| 2021 | 1 | 7 | 8 |
| 2022 | 3 | 6 | 9 |
| 2023 | 1 | 5 | 6 |
| 2024 | 7 | 1 | 8 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dronabinol" by people in Profiles.
-
Aks IR, Patel H, Pelham WE, Huestis MA, Wade NE. Cannabinoids in hair and their prospective association with mental and physical health outcomes in adolescents. Neurotoxicol Teratol. 2025 Mar-Apr; 108:107433.
-
Cieri G, Mohr ALA, Fogarty M, Chan-Hosokawa A, Logan BK. Four-year evaluation of drug-impaired driving drug concentrations. J Anal Toxicol. 2024 Nov 15; 48(9):641-652.
-
Sempio C, Campos-Palomino J, Klawitter J, Harrison A, Peters EN, MacNair L, Haghdoost M, Bonn-Miller M, Babalonis S, Huestis MA, Christians U, Klawitter J. LC-MS-MS quantification of ?8-THC, ?9-THC, THCV isomers and their main metabolites in human plasma. J Anal Toxicol. 2024 Aug 21; 48(7):499-506.
-
Torrens A, Mabou Tagne A, Tran A, Ahmed F, Huestis MA, Piomelli D. Comparative Pharmacokinetics of ?9-Tetrahydrocannabinol in Adolescent and Adult Female Mice. Cannabis Cannabinoid Res. 2024 12; 9(6):1537-1542.
-
Shuda SA, Folger JF, Spargo E, Logan BK. Development and validation of a quantitative method for the analysis of delta-9-tetrahydrocannabinol (delta-9-THC), delta-8-tetrahydrocannabinol (delta-8-THC), delta-9-tetrahydrocannabinolic acid (THCA), and cannabidiol (CBD) in botanicals, edibles, liquids, oils, waxes, and bath products by gas chromatography mass spectrometry (GC/MS). J Forensic Sci. 2024 Sep; 69(5):1718-1729.
-
Goldman M, Markov DD. Why Ask Patients to Cut Into Quarters 10-mg THC Gummies Obtained From a Cannabis Dispensary When 2.5-mg THC (Dronabinol) Is Available by Prescription? J Clin Psychiatry. 2024 Jun 05; 85(2).
-
Fogel H, Yeritsyan D, Momenzadeh K, Kheir N, Yeung CM, Abbasian M, Lozano EM, Nazarian RM, Nazarian A. The effect of cannabinoids on single-level lumbar arthrodesis outcomes in a rat model. Spine J. 2024 09; 24(9):1759-1772.
-
Scherer JN, Vasconcelos M, Dalanhol CS, Govoni B, Dos Santos BP, Borges GR, de Gouveia GC, Viola PP, Carlson RLR, Martins AF, Costa JL, Huestis MA, Pechansky F. Reliability of roadside oral fluid testing devices for ?9-tetrahydrocannabinol (?9-THC) detection. Drug Test Anal. 2024 Dec; 16(12):1528-1536.
-
Rozanc J, Klumpers LE, Huestis MA, Tagen M. Tolerability of High-Dose Oral ?9-THC: Implications for Human Laboratory Study Design. Cannabis Cannabinoid Res. 2024 04; 9(2):437-448.
-
Cliburn KD, Kemp PM, Huestis MA, Wagner JR, Payton M, Liu L, Liang Y, Maxwell LK. Time- and?temperature-dependent postmortem ?9-tetrahydrocannabinol concentration changes in?rabbits following controlled inhaled cannabis administration. J Anal Toxicol. 2023 Dec 12; 47(9):850-857.